Work

Supplementary Figure 4 from BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 77K, 18FFAC PET imaging of adoptively transferred splenocytes with or without vemurafenib

DOI: 10.1158/0008-5472.22393532.v1

Authors: Richard C. Koya, Stephen Mok, Nicholas Otte, Kevin J. Blacketor, Begonya Comin-Anduix, Paul C. Tumeh, Aspram Minasyan, Nicholas A. Graham, Thomas G. Graeber, Thinle Chodon, Antoni Ribas

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361833433

Cites:

Cited by:

Related to: 10